Risdiplam
Other Drugs For Disorders Of The Musculo-Skeletal System
Sold as Evrysdi
- Drug class
- Other Drugs For Disorders Of The Musculo-Skeletal System
- Availability
- See label
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 6
Overview
Risdiplam is an active pharmaceutical ingredient in the Other Drugs For Disorders Of The Musculo-Skeletal System group (M09AX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 3 | May 1, 2026 |
| EU European Union | EMA | 1 | April 21, 2026 |
| CA Canada | Health Canada | 2 | May 21, 2026 |
GBUnited Kingdom· MHRA
3 products
Uses
Evrysdi is indicated for the treatment of 5q spinal muscular atrophy (SMA) in patients with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies.
How to take
EUEuropean Union· EMA
1 product
Uses
Evrysdi is indicated for the treatment of 5q spinal muscular atrophy (SMA) in patients with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies.
How to take
CACanada· Health Canada
2 products
2 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].
Brands in Canada (1)
Drug interactions
Known interactions involving Risdiplam. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL000310945 · revised January 30, 2026
- [2]European Medicines Agency · EMEA/H/C/005145 · revised April 21, 2026
- [3]Health Canada (DPD) · 02514931 · revised May 21, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.